OnKure Positioned for Success with PI3Kα Inhibitor OKI-219 in Breast Cancer
Targeting H1047R Mutations for Improved Efficacy and Reduced Toxicity in an Expanding Market OnKure Therapeutics (OKUR) is making waves in ...
Targeting H1047R Mutations for Improved Efficacy and Reduced Toxicity in an Expanding Market OnKure Therapeutics (OKUR) is making waves in ...
Over 3 Million Lose Power as the Storm Moves Offshore, with Damages Estimated Between $60-$75 Billion Hurricane Milton swept through ...
Washington’s Push Against Big Tech Escalates as Justice Department Targets Google’s Dominance in Search The U.S. Department of Justice (DOJ) ...
Sales Fall Short of Expectations as the Company Navigates Inflation, Geopolitical Tensions, and Shifting Consumer Spending PepsiCo (PEP) has revised ...
What Investors Can Expect from Tesla's AI Innovations and Production Updates Tesla (TSLA) is gearing up for its much-anticipated AI ...
Potential Upside in Obesity Treatment as Higher Dose Efficacy Data Expected to Boost Competitive Profile Viking Therapeutics (VKTX) is gearing ...
Mixed Economic Signals from Japan and South Korea Add to Investor Caution Across Asia-Pacific Markets The Chinese stock market’s early ...
AI Server Maker Super Micro Gains 14% Amid Growing Demand for AI Hardware and Rising Short-Seller Pressure Super Micro Computer ...
Major trials signal potential advancements in cancer treatment and rare disease therapies Biotech companies are preparing for significant milestones as ...
Solid Sales Growth with Potential Speedbumps in the Final Quarter of 2024 Carvana (CVNA) continues to show resilience and momentum ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?